Congenital absence of both forearm and hand, bilateral

Summary

Congenital absence of both forearm and hand, bilateral (MONDO:0017499) is a disease. A subtype of congenital absence of both forearm and hand — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	congenital absence of both forearm and hand, bilateral
Mondo ID	MONDO:0017499
Orphanet	295095
ICD-10-CM	Q71.23
ICD-11	1524444518
UMLS	C2910270
MedGen	1843505
GARD	0025101
Is cancer (heuristic)	no

Also known as: radio-ulnar terminal transverse meromelia, bilateral

Disease family

This is a subtype of congenital absence of both forearm and hand. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › skeletal dysplasia › congenital absence of both forearm and hand › congenital absence of both forearm and hand, bilateral

Related subtypes (1): congenital absence of both forearm and hand, unilateral

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.